Video
A floppy baby - could it have Spinal Muscular Atrophy (SMA)? With disease-modifying treatments for SMA now funded in New Zealand, early recognition and diagnosis are essential to achieve good treatment outcomes.
In this session, Gina will cover:
- What is SMA?
- How common is it?
- Diagnosis of SMA
- Referral pathways
- Management
- Update on disease-modifying therapy now funded in New Zealand.
Presenter
Gina O’Grady
Paediatric Neurologist
Gina is a Paediatric Neurologist at Starship Children’s Hospital. She has a subspeciality interest in paediatric neuromuscular disease and genetic diagnosis.
She runs a neuromuscular management clinic at Starship Children’s Hospital and has led the rollout of disease-modifying therapy for the treatment of Spinal Muscular Atrophy (SMA) in New Zealand.
This webinar was DEVELOPED INDEPENDENTLY BY GOODFELLOW UNIT with our expert speaker. THE IDEA FOR EDUCATION ON THE IDENTIFICATION OF INFANTS AND CHILDREN WITH SMA WAS PROPOSED BY BIOGEN NEW ZEALAND, THE SPONSORING COMPANY.
